EGRIFTA WR
tesamorelin · KIT · Theratechnologies Inc.
No Recall History
Plain English
EGRIFTA WR is a kit containing tesamorelin, taken subcutaneous. Manufactured by Theratechnologies Inc..
Key Facts
- Brand Name
- EGRIFTA WR
- Generic Name
- tesamorelin
- NDC Code (Product)
62064-381- Manufacturer
- Theratechnologies Inc.
- Dosage Form
- KIT
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA022505
- Marketing Start
- 07/15/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is EGRIFTA WR used for?
EGRIFTA WR contains tesamorelin. It is a kit taken subcutaneous. Consult your doctor for specific uses.
Is EGRIFTA WR a controlled substance?
EGRIFTA WR is not classified as a controlled substance by the DEA.
What is the generic name for EGRIFTA WR?
The generic name for EGRIFTA WR is tesamorelin. There are 1 other brand versions of tesamorelin.
What is the NDC code for EGRIFTA WR ?
The NDC (National Drug Code) for EGRIFTA WR is 62064-381, listed by Theratechnologies Inc..